Elinogrel, an orally and intravenously available ADP-receptor antagonist. How does elinogrel affect a personalized antiplatelet therapy? 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Elinogrel, an orally and intravenously available ADP-receptor antagonist. How does elinogrel affect a personalized antiplatelet therapy?

引用本文：	Müller KA,Geisler T,Gawaz M.Elinogrel, an orally and intravenously available ADP-receptor antagonist. How does elinogrel affect a personalized antiplatelet therapy?[J].Hamostaseologie,2012,32(3):191-194.

作者姓名：	Müller KA Geisler T Gawaz M

摘要：
本文献已被 PubMed 等数据库收录！